Corporate Banner
Satellite Banner
Molecular & Clinical Diagnostics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

After Cancer Diagnosis, Breast Density May Not Matter

Published: Tuesday, September 11, 2012
Last Updated: Tuesday, September 11, 2012
Bookmark and Share
Women with breasts that look dense on a mammogram have a higher risk of developing breast cancer.

But a new study found that most of these women, once diagnosed with breast cancer, aren't at greater risk of dying than patients with less dense breasts.

Mammograms use X-rays to create an image of the breast. Dense regions made up of non-fatty tissues block the passage of X-rays and show up as white. Fatty, less-dense regions of the breast look darker because X-rays pass through more easily.

Past research has found that women with denser breasts have a greater risk of developing breast cancer. However, studies that evaluate what happens to women with dense breasts after they're diagnosed with breast cancer have found conflicting results.

To address this question, a research team led by Dr. Gretchen Gierach of NIH's National Cancer Institute (NCI) used data from the NCI-sponsored Breast Cancer Surveillance Consortium, which collects data from breast imaging facilities in the United States. The consortium gathers information on breast cancer risk factors, results of mammograms and other disease details.

The researchers analyzed data from more than 9,000 women who were 30 years or older when they were diagnosed with breast cancer. The women were followed, on average, for 6.6 years. Nearly 900 died of breast cancer in that time and over 800 from other causes. Another 96 died of unknown causes. The team's findings were published on August 22, 2012, in the Journal of the National Cancer Institute.

Breast cancer patients with dense breasts didn't appear to have a higher risk of death from breast cancer than patients with less dense breasts. In the analysis, the scientists took into account the particular characteristics of the women's tumors and several other factors, including body mass index, income and the type of cancer treatment they had.

The researchers did find an increased risk of death from breast cancer among specific subgroups of patients with less dense breasts, including those who are obese. The scientists speculate that fatty breasts might be a hospitable environment for cancer growth.

“Overall, it was reassuring to find that high mammographic breast density, one of the strongest risk factors for breast cancer, was not related to risk of death from breast cancer or death from any cause among breast cancer patients,” Gierach says.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More than 3,800+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Tumor DNA in Blood Reveals Lymphoma Progression
Using an advanced genetic test, researchers were able to detect diffuse large B-cell lymphoma (DLBCL) in blood serum before it could be seen on CT scans.
Tuesday, April 14, 2015
NIH Funds Nine Antimicrobial Resistance Diagnostics Projects
Investigators to develop tools to detect hospital-associated pathogens.
Friday, April 10, 2015
NIH Launches Tool to Advance Down Syndrome Research
Web portal will help approved professionals to plan clinical studies.
Wednesday, January 28, 2015
Sophisticated HIV Diagnostics Adapted For Remote Areas
New tool is low-cost, with no electricity needed.
Tuesday, December 02, 2014
NIH Names New Clinical Sites in Undiagnosed Diseases Network
Four-year, $43 million initiative engages broad expertise in study of mystery conditions.
Wednesday, July 02, 2014
Genetic Disorder Causing Strokes, Vascular Inflammation in Children Discovered
NIH researchers have identified gene variants that cause a rare syndrome of sporadic fevers, skin rashes and recurring strokes, beginning early in childhood.
Thursday, February 20, 2014
NIH, Industry and Non-Profits Join Forces to Speed Validation of Disease Targets
Goal is to develop new treatments earlier, beginning with Alzheimer's, type 2 diabetes, and autoimmune disorders.
Tuesday, February 11, 2014
Speeding Validation of Disease Targets
NIH, industry and non-profits join forces to develop new treatments earlier, beginning with Alzheimer’s, type 2 diabetes, and autoimmune disorders.
Tuesday, February 04, 2014
First Evidence-Based Diagnostic Criteria Published For TMD
The first evidence-based diagnostic criteria have been developed to help health professionals better diagnose temporomandibular disorders, commonly known as TMJ.
Monday, February 03, 2014
Earliest Marker for Autism Found in Young Infants
NIH-funded study finds attention to others’ eyes declines in 2 to 6-month-old infants later diagnosed with autism.
Thursday, November 07, 2013
NIH Announces 15 Clinical and Translational Science Awards
Awards aim to help translate scientific discoveries to improved health.
Tuesday, October 22, 2013
NIH-Funded Study Suggests Brain is Hard-Wired for Chronic Pain
The results, published in the journal Pain, support the growing idea that the brain plays a critical role in chronic pain.
Tuesday, September 17, 2013
NIH Grants to Investigate Disease-Related Variations in Genetic Makeup
Studies focus on underlying susceptibilities in minority populations.
Monday, September 09, 2013
NIH Funds Research to Explore a Cell Communication Process
Researchers will investigate the emerging field of extracellular RNA and its role in human health conditions.
Wednesday, August 14, 2013
Rapid Test Allows for Earlier Diagnosis of Tuberculosis in Children
A new test for diagnosing TB in children detects roughly two-thirds of cases identified by the current culture test, but in a fraction of the time.
Thursday, July 25, 2013
Scientific News
‘Mutation-Tracking’ Blood Test for Breast Cancer
Scientists have developed a blood test for breast cancer able to identify which patients will suffer a relapse after treatment, months before tumours are visible on hospital scans.
Common ‘Heart Attack’ Blood Test May Predict Future Hypertension
Small rises in troponin levels may have value as markers for subclinical heart damage and high blood pressure.
Poor Survival Rates in Leukemia Linked to Persistent Genetic Mutations
For patients with an often-deadly form of leukemia, new research suggests that lingering cancer-related mutations – detected after initial treatment with chemotherapy – are associated with an increased risk of relapse and poor survival.
'Fountain of Youth' Protein Points to Possible Human Health Benefit
Patients with higher blood levels of growth factor have lower risk of cardiovascular problems.
Signature of Microbiomes Linked to Schizophrenia
Studying microbiomes in throat may help identify causes and treatments of brain disorder.
Imaging Software Could Speed Breast Cancer Diagnosis
Technology could improve access to diagnostic services in developing countries.
The Changing Tides of the In Vitro Diagnostics Market
With the increasing focus in personalized medicine, diagnostics plays a crucial role in patient monitoring.
Data Mining DNA For Polycystic Ovary Syndrome Genes
A new Northwestern Medicine genome-wide association study of PCOS – the first of its kind to focus on women of European ancestry – has provided important new insights into the underlying biology of the disorder.
Algorithm Interprets Breathing Difficulties to Aid in Medical Care
Researchers from North Carolina State University have developed an efficient algorithm that can interpret the wheezing of patients with breathing difficulties to give medical providers information about what’s happening in the lungs.
Researchers Develop qPCR Prognosis Test for NSCLC Patients
A nine-gene molecular prognostic index (MPI) for patients with early-stage non-small cell lung cancer (NSCLC) was able to provide accurate survival stratification and could potentially inform the use of adjuvant therapy in patients struggling with the disease.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!